FONAR Corporation Reports Q2 Fiscal 2026 Financial Results with Increased Revenue and Net Income

FONAR Corporation reported its financial results for the second quarter of fiscal 2026, revealing a net income of $2.5 million on revenues of $25.5 million, compared to a net income of $2.2 million on revenues of $25.0 million for the same period in the previous year. For the six months ended December 31, 2025, the company generated $51.6 million in revenue, a slight increase from $50.0 million in the prior year, while net income decreased to $5.2 million from $6.2 million. The decline in profitability was attributed to rising costs outpacing revenue growth, with total costs and expenses increasing by 5.9% to $45.4 million.

The company experienced a notable increase in management and other fees, which rose by $1.3 million to $31.8 million for the first half of fiscal 2026. However, patient fee revenue decreased by approximately $560,000, reflecting challenges in the healthcare reimbursement landscape. FONAR's service and repair fees also saw growth, increasing to $4.5 million for the first half of fiscal 2026, up from $3.8 million in the same period last year. The total number of scans performed at FONAR-managed sites increased to 109,952, up from 106,168, attributed to the absence of hurricane-related closures experienced in the previous year.

In terms of operational developments, FONAR continues to manage 45 MRI scanners, with 27 located in New York and 18 in Florida. The company is also in the process of a proposed merger, having entered into a Merger Agreement on December 23, 2025, with FONAR, LLC, an entity controlled by CEO Timothy Damadian. The merger is expected to close by March 12, 2026, subject to various conditions, including stockholder approval. The proposed transaction will convert shares of FONAR stock into cash, with specific prices set for different classes of stock.

FONAR's balance sheet as of December 31, 2025, showed total assets of $217.2 million, a slight increase from $216.9 million at the end of June 2025. Current liabilities decreased to $14.4 million from $17.1 million, contributing to an increase in working capital to $129.4 million. The company reported cash and cash equivalents of $53.0 million, down from $56.3 million at the end of the previous fiscal year. FONAR's management remains focused on enhancing operational efficiency and expanding its market presence, particularly in the diagnostic imaging sector, while navigating the challenges posed by rising costs and competitive pressures in the healthcare industry.